Eric McLaughlin
Impact in
-
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
-
- Virus-based gene therapy research
Papers in
- Co-authors
- Xiaoli Zhang (3 shared papers)Vivek Bhaskaran (1 shared paper)Sean Lawler (1 shared paper)Hirotaka Ito (1 shared paper)Hiroshi Nakashima (1 shared paper)Isabel DeLaura (1 shared paper)E. Antonio Chiocca (1 shared paper)Maria C. Speranza (1 shared paper)
- Journals
- Blood (8 papers)Gynecologic Oncology (4 papers)International Journal of Gynecological Cancer (2 papers)Journal of Surgical Research (2 papers)Journal of Cancer Survivorship (2 papers)
- Partner nations
- United StatesSaudi ArabiaEthiopia
In The Last Decade
Eric McLaughlin
51 papers receiving 394 citations
Peers
Comparison fields: 5 of 79
- Oncology 213
- Genetics 35
- Immunology 69
- Obstetrics and Gynecology 24
- Genetics 81
Countries citing papers authored by Eric McLaughlin
This map shows the geographic impact of Eric McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric McLaughlin more than expected).
Fields of papers citing papers by Eric McLaughlin
This network shows the impact of papers produced by Eric McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric McLaughlin. The network helps show where Eric McLaughlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 103 | |
| 2 | 2019 | 51 | |
| 3 | 2021 | 30 | |
| 4 | 2017 | 27 | |
| 5 | 2022 | 14 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 11 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 10 | |
| 10 | 2018 | 10 | |
| 11 | 2023 | 8 | |
| 12 | 2019 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2023 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2021 | 4 |
About Eric McLaughlin
Eric McLaughlin is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 61 papers that have together received 396 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Colorectal Cancer Screening and Detection (4 papers), T-cell and Retrovirus Studies (4 papers), Cancer Risks and Factors (4 papers) and Pelvic floor disorders treatments (3 papers). The work is most often cited by research in Oncology (213 citations), Genetics (35 citations), Immunology (69 citations), Obstetrics and Gynecology (24 citations) and Genetics (81 citations). Eric McLaughlin has collaborated with scholars based in United States, Saudi Arabia and Ethiopia. Frequent co-authors include Xiaoli Zhang, Vivek Bhaskaran, Sean Lawler, Hirotaka Ito, Hiroshi Nakashima, Isabel DeLaura, E. Antonio Chiocca, Maria C. Speranza, Electra D. Paskett and Khalid Shah. Their work appears in journals such as Blood, Gynecologic Oncology, International Journal of Gynecological Cancer, Journal of Surgical Research and Journal of Cancer Survivorship.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.